Barclays Maintains Underweight on FMC, Lowers Price Target to $4
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Underweight and lowers the price target from $9 to $4.
Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Underweight and lowers the price target from $9 to $4.